272 related articles for article (PubMed ID: 22031485)
21. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older.
Cober ED; Malani PN
J Am Geriatr Soc; 2009 Apr; 57(4):659-62. PubMed ID: 19392957
[TBL] [Abstract][Full Text] [Related]
23. Host and pathogen factors for Clostridium difficile infection and colonization.
Loo VG; Bourgault AM; Poirier L; Lamothe F; Michaud S; Turgeon N; Toye B; Beaudoin A; Frost EH; Gilca R; Brassard P; Dendukuri N; Béliveau C; Oughton M; Brukner I; Dascal A
N Engl J Med; 2011 Nov; 365(18):1693-703. PubMed ID: 22047560
[TBL] [Abstract][Full Text] [Related]
24. Reduction in Clostridium difficile infections in Finland, 2008-2010.
Kanerva M; Mentula S; Virolainen-Julkunen A; Kärki T; Möttönen T; Lyytikäinen O;
J Hosp Infect; 2013 Feb; 83(2):127-31. PubMed ID: 23201398
[TBL] [Abstract][Full Text] [Related]
25. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center.
Honda H; Yamazaki A; Sato Y; Dubberke ER
Anaerobe; 2014 Feb; 25():5-10. PubMed ID: 24184291
[TBL] [Abstract][Full Text] [Related]
26. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
[TBL] [Abstract][Full Text] [Related]
27. Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.
Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Anaerobe; 2014 Dec; 30():65-9. PubMed ID: 25219941
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological and genomic characterization of community-acquired Clostridium difficile infections.
Thornton CS; Rubin JE; Greninger AL; Peirano G; Chiu CY; Pillai DR
BMC Infect Dis; 2018 Aug; 18(1):443. PubMed ID: 30170546
[TBL] [Abstract][Full Text] [Related]
29. What is on that keyboard? Detecting hidden environmental reservoirs of Clostridium difficile during an outbreak associated with North American pulsed-field gel electrophoresis type 1 strains.
Dumford DM; Nerandzic MM; Eckstein BC; Donskey CJ
Am J Infect Control; 2009 Feb; 37(1):15-9. PubMed ID: 19171247
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for the development of Clostridium difficile infection in hospitalized children.
Samady W; Pong A; Fisher E
Curr Opin Pediatr; 2014 Oct; 26(5):568-72. PubMed ID: 25032717
[TBL] [Abstract][Full Text] [Related]
31. Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh.
Reddy S; Taori S; Poxton IR
Clin Microbiol Infect; 2010 Apr; 16(4):340-6. PubMed ID: 20222891
[TBL] [Abstract][Full Text] [Related]
32. Clostridium difficile infection in children: a comprehensive review.
Pant C; Deshpande A; Altaf MA; Minocha A; Sferra TJ
Curr Med Res Opin; 2013 Aug; 29(8):967-84. PubMed ID: 23659563
[TBL] [Abstract][Full Text] [Related]
33. Influence of cohorting patients with Clostridium difficile infection on risk of symptomatic recurrence.
Islam J; Cheek E; Navani V; Rajkumar C; Cohen J; Llewelyn MJ
J Hosp Infect; 2013 Sep; 85(1):17-21. PubMed ID: 23910403
[TBL] [Abstract][Full Text] [Related]
34. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.
Goorhuis A; Bakker D; Corver J; Debast SB; Harmanus C; Notermans DW; Bergwerff AA; Dekker FW; Kuijper EJ
Clin Infect Dis; 2008 Nov; 47(9):1162-70. PubMed ID: 18808358
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
36. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.
Gravel D; Miller M; Simor A; Taylor G; Gardam M; McGeer A; Hutchinson J; Moore D; Kelly S; Boyd D; Mulvey M;
Clin Infect Dis; 2009 Mar; 48(5):568-76. PubMed ID: 19191641
[TBL] [Abstract][Full Text] [Related]
37. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
[TBL] [Abstract][Full Text] [Related]
38. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
39. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
[TBL] [Abstract][Full Text] [Related]
40. Obesity as a risk factor for Clostridium difficile infection.
Bishara J; Farah R; Mograbi J; Khalaila W; Abu-Elheja O; Mahamid M; Nseir W
Clin Infect Dis; 2013 Aug; 57(4):489-93. PubMed ID: 23645850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
